Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

YTT 101

Next Previous
X
Search
Drug Profile

YTT 101

Alternative Names: CMV (T cell Receptor) T cell therapy - China Immunotech; CMV TCR T cell therapy - China Immunotech; CMV-TCR-T; YTT101

Latest Information Update: 28 Feb 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator China Immunotech
  • Developer China Immunotech; Peking University People's Hospital
  • Class Gene therapies; Immunotherapies; T lymphocyte cell therapies
  • Mechanism of Action Immunologic cytotoxicity; T lymphocyte replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Cytomegalovirus infections

Most Recent Events

  • 28 Feb 2024 No recent reports of development identified for phase-I development in Cytomegalovirus infections(Treatment-experienced) in China (IV, Infusion)
  • 28 Jan 2023 No recent reports of development identified for phase-I development in Cytomegalovirus infections(In adolescents, In children, In the elderly, In infants, Treatment-experienced, In adults) in China (IV, Infusion)
  • 15 Nov 2022 China Immunotech and Hebei Yanda Ludaopei Hospital completes a phase I trial in Cytomegalovirus infections (In infants, In children, In adolescents, In adults, In the elderly;Treatment-experienced) in China (IV) (NCT04153279)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top